FDC
Back to Income Statement
|
FDC Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹267 Cr | ₹305 Cr | ₹194 Cr | ₹216 Cr | ₹301 Cr |
What is the latest Consolidated Net Profit of FDC ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹267 Cr |
| Mar2024 | ₹305 Cr |
| Mar2023 | ₹194 Cr |
| Mar2022 | ₹216 Cr |
| Mar2021 | ₹301 Cr |
How is Consolidated Net Profit of FDC Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹267 Cr | -12.55 | |
| Mar2024 | ₹305 Cr | 57.22 | |
| Mar2023 | ₹194 Cr | -10.33 | |
| Mar2022 | ₹216 Cr | -28.19 | |
| Mar2021 | ₹301 Cr | - | |
Compare Consolidated Net Profit of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹5,746.8 Cr | -5.1% | -9.5% | -8.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,000.0 Cr | -0.4% | 5.3% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -4.3% | -6.3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 0.4% | 8.2% | 44.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 0.5% | 1.8% | 16.4% | Stock Analytics | |
| CIPLA | ₹106,150.0 Cr | -0.8% | -2.6% | -9.2% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -5.1% |
-9.5% |
-8.7% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses